Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.19.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Valuation Allowance

The activity in the deferred tax valuation allowance was as follows for the years ended December 31, 2018 and 2017:

 

    Year ended December 31,  
    2018     2017  
Beginning balance   $ 6,620,464     $ 7,221,443  
Provision/ (Benefit)     400,158       (648,281 )
Adjustments/true-ups     155,769       47,302  
Ending balance   $ 7,176,391     $ 6,620,464  

Schedule of Income before Income Tax, Domestic and Foreign

The (loss) income before tax for financial reporting purposes during the years ended December 31, 2018 and 2017 consisted of the following:

 

    Year ended December 31,  
    2018     2017  
United States   $ (4,111,539 )   $ (6,949,433 )
Foreign     1,815,674       1,452,082  
Total   $ (2,295,865 )   $ (5,497,351 )

Schedule of Components of Income Tax Expense (Benefit)

The (benefit) provision for income taxes for the years ended December 31, 2018 and 2017 consisted of the following:

 

    Year ended December 31,  
    2018     2017  
Current:            
Federal   $ -     $ -  
State     49,000       31,028  
Foreign     1,341       10,235  
      50,341       41,263  
Deferred:                
Federal     (225,347 )     7,183  
State     17,621       19,359  
      (207,726 )     26,542  
Total income tax (benefit) provision   $ (157,385 )   $ 67,805  

Schedule of Deferred Tax Assets and Liabilities

The components of the Company’s deferred income taxes as of December 31, 2018 and 2017 are as follows:

 

    December 31, 2018     December 31, 2017  
Deferred tax assets:                
Allowance for doubtful accounts   $ 46,492     $ 45,944  
Deferred revenue     4,664       7,121  
Deferred rent     4,275       1,857  
Property and intangible assets     2,336,221       2,227,454  
State net operating loss (“NOL”) carryforwards     636,578       569,847  
Federal net operating loss (“NOL”) carryforwards     3,789,618       3,245,846  
Section 163(j) interest limitation     51,319       -  
Cumulative translation adjustment     349,834       179,510  
Stock based compensation     335,785       325,243  
Other     (24,654 )     17,642  
Valuation allowance     (7,176,391 )     (6,620,464 )
Total deferred tax assets     353,741       -  
Deferred tax liabilities:                
Goodwill amortization     (518,087 )     (372,072 )
Net deferred tax liability   $ (164,346 )   $ (372,072 )

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the federal statutory income tax rate (21%) for 2018 and (34%) for 2017 to the Company’s effective income tax rate (determined in dollars) for the years ended December 31, 2018 and 2017 is as follows:

 

    Year ended December 31,
    2018     2017  
Federal benefit at statutory rate   $ (482,132 )   $ (1,869,100 )
Increase (decrease) in income taxes resulting from:                
State tax expense, net of federal benefit     29,646       27,733  
Non-deductible items     15,332       18,168  
Impact of foreign operations     (525,583 )     (733,043 )
Deferred tax impact from rate change     -       3,105,106  
Subpart F GILTI inclusion     360,742       -  
Deferred true-up     (142,869 )     (42,453 )
Valuation allowance     555,927       (600,978 )
Additional tax goodwill/contingent consideration     31,553       162,372  
Total income tax (benefit) provision   $ (157,385 )   $ 67,805